RECRUITING

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions. This study aims to compare two methods of delivering cardiac rehabilitation: in-person and through telehealth. The investigators want to know if the effects of these two programs are alike and if certain individuals benefit more from one program over the other.

Official Title

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Quick Facts

Study Start:2023-10-27
Study Completion:2027-10-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05933083

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 18 or older
  2. 2. Eligible for cardiac rehabilitation
  3. 1. Diagnosis within 1 year prior to consent
  4. * Myocardial infarction
  5. * Percutaneous coronary intervention
  6. * Coronary artery bypass
  7. * Heart valve repair or replacement
  8. * Heart transplant
  9. 2. Chronic stable angina, or
  10. 3. Chronic systolic heart failure (ejection fraction ≤ 35%)
  11. 4. Referred to cardiac rehabilitation by a doctor or advanced practice provider for another indication that is covered by the participant's insurance, such as heart failure with preserved ejection fraction or aortic surgery.
  12. 3. Willing to be randomized to in-person or telehealth cardiac rehabilitation
  13. 4. Able to communicate in English or Spanish
  1. 1. Unstable arrhythmias which may make unmonitored exercise unsafe (e.g., history of ventricular tachycardia not on medical therapy and without an implantable cardioverter defibrillator)
  2. 2. Unsafe for patient to participate in the opinion of the investigator
  3. 3. Hospice
  4. 4. Unable to consent for self

Contacts and Locations

Study Contact

Alisa Boyd, MPH
CONTACT
415-502-6191
mcnairstudy@ucsf.edu

Principal Investigator

Alexis Beatty, MD, MAS
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California, San Francisco
San Francisco, California, 94143
United States
Johns Hopkins University Medical Center
Baltimore, Maryland, 21287
United States
University of Michigan
Ann Arbor, Michigan, 48105
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Alexis Beatty, MD, MAS, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-27
Study Completion Date2027-10-15

Study Record Updates

Study Start Date2023-10-27
Study Completion Date2027-10-15

Terms related to this study

Keywords Provided by Researchers

  • cardiac rehabilitation, telehealth

Additional Relevant MeSH Terms

  • Myocardial Infarction
  • Heart Failure, Systolic
  • Heart Valve Diseases
  • Angina, Stable
  • Coronary Artery Disease
  • Heart Transplant